(Q48016986)

7 February 2018

title

The effect of aprotinin on transfusion requirements in pediatric orthotopic liver transplantation (English)

1 reference

7 February 2018

main subject

liver transplantation

1 reference

orthotopic liver transplantation

inferred from title

1 reference

Toni M Rentoul

1

1 reference

7 February 2018

Victor L Harrison

series ordinal

2

1 reference

7 February 2018

Albert Shun

series ordinal

3

1 reference

7 February 2018

publication date

1 April 2003

1 reference

7 February 2018

Pediatric Transplantation

published in

1 reference

7 February 2018

volume

7

1 reference

7 February 2018

issue

2

1 reference

7 February 2018

page(s)

142-148

1 reference

7 February 2018

Improved haemodynamic stability with administration of aprotinin during orthotopic liver transplantation.

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00037.X

Prognostic factors for long-term actual patient survival after orthotopic liver transplantation in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00037.X

7 January 2021

Blood transfusion in liver transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00037.X

7 January 2021

Hepatic transplantation in Europe. First Report of the European Liver Transplant Registry

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00037.X

7 January 2021

Coagulation and fibrinolysis in orthotopic liver transplantation: current views and insights

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00037.X

7 January 2021

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00037.X

1 reference

7 January 2021

Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study. EMSALT Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00037.X

7 January 2021

Aprotinin reduces red blood cell transfusion in orthotopic liver transplantation: a prospective, randomized, double-blind study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00037.X

7 January 2021

Aprotinin in pediatric cardiac operations: a benefit in complex malformations and with high-dose regimen only

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00037.X

7 January 2021

Pro: the routine use of aprotinin during pediatric cardiac surgery is a benefit

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00037.X

7 January 2021

Aprotinin reduces the need for blood products during liver transplantation.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00037.X

7 January 2021

The prophylactic effect of aprotinin on intraoperative bleeding in liver transplantation: a randomized clinical study.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00037.X

7 January 2021

Effect of aprotinin on intraoperative bleeding and fibrinolysis in liver transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00037.X

7 January 2021

Influence of high-dose aprotinin on hemostasis and blood requirement in orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00037.X

7 January 2021

Aprotinin efficacy on intraoperative bleeding and transfusion requirements in orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00037.X

7 January 2021

Does aprotinin really reduce blood loss in orthotopic liver transplantation?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00037.X

7 January 2021

Reduced need for vasopressors in patients receiving aprotinin during orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00037.X

7 January 2021

10.1034/J.1399-3046.2003.00037.X

Identifiers

DOI

1 reference

7 February 2018

1 reference

7 February 2018